Company Overview and News

Raymond Handling Concepts Corporation Sees Explosive Growth

2016-04-01 marketwired
ATLANTA, GA--(Marketwired - April 01, 2016) -  Raymond Handling Concepts Corporation (RHCC), a leading materials handling equipment supplier in Northern California and the Northwest, has transformed its business to include not only traditional material handling systems, but total end-to-end warehouse management solutions for its customers, resulting in a 35 percent sales growth for 2015. As a part of its expansion and commitment to ensuring customer success, Raymond Handling Concepts has added engineered storage solutions that incorporate pallet rack, shelving and mezzanines, as well as expanded its project management practice and automated storage system products, including Kardex Remstar carousels and vertical lift modules.

Raymond aims at 7-8% growth in suitings biz

2016-03-28 thehindubusinessline
Raymond Textiles, a part of fabric manufacturer and apparel maker Raymond Ltd, is targeting a 7-8 per cent growth in its suitings business next fiscal.


2016-03-25 caselaw.findlaw
Pamela Scott, Personal Representative of the Estate of Michael E. Scott, Deceased; Roadtex Transportation Corp.; Roadtex Corp.—Bayonne, NJ; Roadtex Corp.—Colts Neck, NJ; Roadtex Logistics, LLC; Roadtex Transportation Management Corp., Defendants v. Associated Wholesale Grocers, Inc., a Kansas Corporation, Defendant–Appellee Pamela Scott, Personal Representative of the Estate of Michael E. Scott, Deceased; Albatross Express, LLC; Roadtex Corp.

Raymond to raise Rs 100 crore via NCDs

2016-02-09 moneycontrol
The Committee of Directors of the Company at a meeting held on February 9, 2016, approved the issue of Non-Convertible Debentures aggregating up to an amount of Rs 100 crore on private placement basis, Raymond said in a BSE filing...

Raymond to keep ad/promotion expenditure at 4-5% of sales

2016-01-24 thehindubusinessline
Raymond Ltd plans to keep its spend on advertising and promotion at 4-5 per cen

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...